Category

Harm Reduction

← All posts
Executive

What Happens in a Psychedelic Therapy Session: A Full Walk-Through

A professionally supported psychedelic experience is a structured, clinically informed process that unfolds across several weeks. Understanding what happens in a psychedelic therapy session requires looking...

April 29, 2026 · 8 min
Conditions

Ibogaine Opioid Treatment Research: What 2025-2026 Studies Found

Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal...

April 28, 2026 · 9 min
Executive

Executive Burnout Psychedelic Therapy: What the Research Shows

Executive burnout psychedelic therapy is moving from the research margins into serious clinical conversation. A growing body of peer-reviewed evidence suggests that psilocybin-assisted therapy can reduce...

April 26, 2026 · 8 min
Substance Deep-Dives

Ayahuasca Therapy Guide: What to Know Before You Go

This ayahuasca therapy guide covers what you need to know before considering a ceremony or retreat: how it works pharmacologically, what the safety risks actually are,...

April 23, 2026 · 10 min
Harm Reduction

Psychedelic Therapy Privacy: What Executives Need to Know

Psychedelic therapy privacy is one of the most legitimate concerns executives and public figures raise before pursuing treatment. HIPAA protections apply to licensed clinical providers, and...

April 19, 2026 · 9 min
Conditions

Set and Setting in 2026: A Psychedelic Preparation Guide for High-Performers

Set and setting psychedelics research refers to the two core non-pharmacological factors that shape a psilocybin experience: your internal state (set) and the physical and relational...

April 17, 2026 · 9 min
Guides

Why Choosing the Right Psychedelic Guide Matters More Than You Think?

Quick answer: The right psychedelic guide is someone who combines safety awareness, strong boundaries, real preparation, and integration support with a communication style and presence that...

March 21, 2026 · 8 min
Legal / Policy / Geo-Legal

MDMA Therapy FDA Decision, What the Rejection Letter Means for Seekers

The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time,...

November 22, 2025 · 8 min
Guides

Ketamine Therapy Preparation: What to Expect and Why It Matters

Ketamine therapy preparation is not a formality you complete before the real thing begins. It is a functional part of what makes the treatment work. What...

August 12, 2025 · 10 min
AI

AI Digital Tripsitter: What It Can and Cannot Do for You

An AI digital tripsitter is a software tool, usually an app or chatbot, designed to support psychedelic experiences through journaling prompts, intention-setting, and guided reflection. These...

July 25, 2025 · 8 min

Ready to take the next step?

Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.